Histology & Cytology Market Size
| Study Period | 2018 - 2028 |
| Base Year For Estimation | 2021 |
| Forecast Data Period | 2024 - 2028 |
| CAGR | 13.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Histology & Cytology Market Analysis
The Histology and Cytology Market is expected to register a CAGR of 13.5% during the forecast period.
COVID-19 is expected to have a significant impact on the growth of the market. This is mainly due to the efficacy of histology tests for the detection of COVID-19 in infected patients. According to the article titled " Clinical characteristics and histopathology of COVID-19 related deaths in South African Adults " published in January 2020 lung histopathology findings showed differences between COVID patients in the severity of the morphological appearance of Type -II pneumocytes, alveolar injury, and repair initiated by SARS-CoV-2 infection. Thus, the above-mentioned factors are expected to drive the growth of the market during the pandemic period.
The propelling factors for the growth of the histology and cytology market include the rising prevalence of cancer, increasing standardization of pathological laboratories, and technological advancements in diagnostic and molecular techniques,
The increasing burden of cancer on society is found to be a major threat to developing countries, owing to lower disposable income and dynamic demographics. Cancer has been the leading cause of mortality, globally and has resulted in deaths that have accounted for the largest share of mortality.
According to the September 2021 update by the World Health Organization (WHO), the most common cancer in 2020 (in terms of new cases of cancer) were: breast (2.26 million cases); lung (2.21 million cases); colon, and rectum (1.93 million cases); prostate (1.41 million cases); skin (non-melanoma) (1.20 million cases); and stomach (1.09 million cases). Thus, the growing prevalence of cancer patients has a direct impact on the increased demand for the histology and cytology market. These histological methods thus help in increasing the sensitivity, specificity, and accuracy of diagnostic methods.
Further, according to the Globocan 2020 report, about 2,206,771 cases of new lung cancer were diagnosed in 2020 around the world, and about 1,796,144 people died because of lung cancer in 2020, globally, which shows a burden of lung cancer. Also, the data published by the World Health Organization in 2020 mentioned that the number of lung cancer cases in 2040 is expected to be 3,503,378. such an increase in lung cancer among the global population is expected to drive the growth of the market.Thus, the prevalence of cancer plays a vital role in increasing the demand for the histology and cytology market.
Furthermore, the histology and cytology market has also experienced huge growth in the healthcare industry as several fatal diseases can be diagnosed through these clinical studies.
Thus, the above mentioned factors are expected to drive the growth of the studied segment during the forecast period.
Histology & Cytology Market Trends
This section covers the major market trends shaping the Histology & Cytology Market according to our research experts:
The Cervical Cancer Segment is Expected to Hold a Major Market Share in the Histology and Cytology Market
Cytology tests are useful for both the diagnosis and screening of cervical cancer. The cytology segment has a wide range of applications in cervical cancer types. Due to the observations at the cellular level, the companies primarily prefer cytology-based diagnostic methods. Since in the coming decade, companies are focusing on diagnosis at the molecular level, cytology is expected to play a vital role.
The cost of histological tests is higher than cytology studies, mainly due to the multiple phases involved in its preparation, whereas no such stages are classified for cytology slides.
According to the World Health Organization Updates in February 2022, Cervical cancer is the fourth most common cancer in women worldwide, with 604,000 new cases and 342,000 deaths by 2020. In 2020, low- and middle-income countries will account for nearly 90% of new cases and deaths worldwide. With the rising adoption of cervical cancer diagnostic tests for the early detection of cervical cancer, the market is expected to grow.
Also, the increasing cervical cancer cytology test approvals are expected to drive the growth of the studied segment during the forecast period. For instance, In March 2020, Roche received United States Food and Drug Administration (FDA) approval of CINtec PLUS Cytology as the first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the human papillomavirus using the cabas 4800 HPV test.
Thus, owing to the above factors during the forecast period, the demand for cervical cancer cytological methods is expected to grow, with more number of companies exploring the method.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the histology and cytology market due to the increasing geriatric population, growing cancer incidence, and raising awareness about cancer screening in this region. For instance, according to the American Cancer Society’s report in 2022 over 1.9 million new cancer cases are expected to be diagnosed in the United States in 2022. and additionally, 80% of the people diagnosed with cancer in the United States are 55 years of age or older and 57% are 65 or older. Thus, due to the high prevalence of cancer, and the rising affected geriatric population, the demand for diagnostics, thereby contributes to the growth of the market.
According to the January 2022 update by breastcancer.org, around 1 in 8 women in the country (about 13%) develop invasive breast cancer over their lifetime. The same source reports that, in 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the United States, as well as 51,400 new cases of non-invasive (in situ) breast cancer. As per the same source, about 2,710 new cases of invasive breast cancer are expected to be diagnosed in men in 2022. A man’s lifetime risk of breast cancer is about 1 in 833. Hence, all these factors are expected to help propel the histology and cytology market.
Additionally, the product approvals in teh United States are also expected to contribute to the growth of the market. for instance, in May 202, Hologic recieved United States Food and Drug Administration premark approval of the Company's ThinPrep Genesis processor for cytology processing and specimen transfer for downsrean applications.
Furthermore, awareness about advance therapeutics and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.
Histology & Cytology Industry Overview
The Histology and Cytology Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the key players operating are Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Hologic Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., and Trivitron Healthcare.
Histology & Cytology Market Leaders
Abbott Laboratories
Becton Dickinson and Company
Merck KGaA
F. Hoffmann-La Roche Ltd
Hologic Inc
*Disclaimer: Major Players sorted in no particular order
Histology & Cytology Market News
- In July 2022, Nanostics Inc launched a prospective clinical study designed to validate a novel and minimally invasive bladder cancer diagnostic test, Clarity DX Bladder using its Clarity DX diagnostic platform.
- In June 2022, The Fine Needle Aspiration Cytology (FNAC) test facility has been launched at the Almora Medical College. This test helps in the detection of chronic diseases like cancer, at an early stage.
Histology & Cytology Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Cancer
4.2.2 Increasing Standardization of Pathological Laboratories
4.2.3 Technological Advancements in Diagnostic and Molecular Techniques
4.3 Market Restraints
4.3.1 Safety Issues and Diagnostic Accuracy Issues with Histopathological and Cytopathological Tests
4.3.2 Lack of Awareness among the Public for Diagnostic Tests
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Type of Examination
5.1.1 Histology
5.1.2 Cytology
5.1.2.1 Breast Cancer
5.1.2.2 Cervical Cancer
5.1.2.3 Others
5.2 By Test Type
5.2.1 Microscopy Tests
5.2.1.1 Cytogenic Tests
5.2.1.1.1 Karyotyping
5.2.1.1.2 Fluorescent In-situ Hybridization (FISH)
5.2.1.2 Polymerase Chain Reaction
5.2.1.3 Other Microscopy Tests
5.2.2 Molecular Genetics Tests
5.2.3 Flow Cytomtery
5.3 By End User
5.3.1 Hospitals and Clinics
5.3.2 Academic and Research Institutes
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott
6.1.2 Becton Dickinson and Company
6.1.3 Danaher
6.1.4 F. Hoffmann-La Roche Ltd
6.1.5 Hologic Inc.
6.1.6 Merck KGaA
6.1.7 PerkinElmer Inc.
6.1.8 Sysmex Corporation
6.1.9 Thermo Fisher Scientific Inc.
6.1.10 Trivitron Healthcare
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Histology & Cytology Industry Segmentation
As per the scope of the report, histology and cytology both come under the scientific medical specialty that is concerned with the diagnosis of diseases and other conditions. Histology is the study of human tissues, including their structure and function whereas cytology is the study of human cells. The Histology and Cytology Market has been segmented by Type of Examination (Histology and Cytology (Breast Cancer, Cervical Cancer and Others)), Test Type (Microscopy Tests (Cytogenic Tests (Karyotyping, Fluorescent In-situ Hybridization (FISH) Polymerase Chain Reaction, Other Microscopy Tests) Molecular Genetics Tests and Flow Cytometry), End-User (Hospitals and Clinics, Academic and Research Institutes and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Type of Examination | |||||
| Histology | |||||
|
| By Test Type | ||||||||
| ||||||||
| Molecular Genetics Tests | ||||||||
| Flow Cytomtery |
| By End User | |
| Hospitals and Clinics | |
| Academic and Research Institutes | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Histology & Cytology Market Research FAQs
What is the current Global Histology and Cytology Market size?
The Global Histology and Cytology Market is projected to register a CAGR of 13.5% during the forecast period (2023-2028).
Who are the key players in Global Histology and Cytology Market?
Abbott Laboratories, Becton Dickinson and Company, Merck KGaA, F. Hoffmann-La Roche Ltd and Hologic Inc are the major companies operating in the Global Histology and Cytology Market.
Which is the fastest growing region in Global Histology and Cytology Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2023-2028).
Which region has the biggest share in Global Histology and Cytology Market?
In 2023, the North America accounts for the largest market share in the Global Histology and Cytology Market.
Global Histology and Cytology Industry Report
Statistics for the 2023 Global Histology and Cytology market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Histology and Cytology analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.
